Clinical Trial Update: Levosimendan Versus Dobutamine for Renal Function in Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 trial comparing levosimendan to dobutamine in patients with cardiorenal syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiorenal Syndrome

Drugs mentioned

• Dobutamine (dobutamine)
• Levosimendan (levosimendan)

Snippet

Sponsor: Göteborg University | Conditions: Cardiorenal Syndrome | Phase 3 | Status: COMPLETED